Latest News

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Altered pain processing in patients with cognitive impairment

  • Social work researchers create easier, accurate way to analyze TSCC trauma results

  • Alzheimer's culprit causes memory loss even before brain degeneration

  • Blood Pressure Medications Can Lead to Increased Risk of Stroke

  • Pembrolizumab shows real promise against head and neck cancer, study suggests

  • A patient's budding cortex -- in a dish? Networking neurons thrive in 3-D human 'organoid'

  • People with multiple sclerosis may have double the risk of dying early

  • Migraine surgery for teens: Good results in initial experience

  • Study shows how students understand mathematics

  • Parents feel racial socialization may help minority children succeed in school

  •